Bei Wang

520 total citations
32 papers, 349 citations indexed

About

Bei Wang is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bei Wang has authored 32 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bei Wang's work include HER2/EGFR in Cancer Research (17 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Peptidase Inhibition and Analysis (9 papers). Bei Wang is often cited by papers focused on HER2/EGFR in Cancer Research (17 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Peptidase Inhibition and Analysis (9 papers). Bei Wang collaborates with scholars based in United States, China and Switzerland. Bei Wang's co-authors include Sandhya Girish, Patricia LoRusso, Yu‐Waye Chu, Ola M. Saad, Amita Joshi, Chunze Li, Surinder Kaur, Qin Yue, Ben‐Quan Shen and Cinthia V. Pastuskovas and has published in prestigious journals such as Journal of Clinical Oncology, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Bei Wang

26 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bei Wang United States 10 261 219 66 47 24 32 349
Cynthia Basu United States 10 230 0.9× 136 0.6× 109 1.7× 63 1.3× 26 1.1× 24 382
Anson K. Abraham United States 12 138 0.5× 103 0.5× 152 2.3× 110 2.3× 29 1.2× 17 353
Mathilde Marchand France 10 255 1.0× 91 0.4× 65 1.0× 120 2.6× 64 2.7× 19 388
Stephen Eppler United States 8 143 0.5× 99 0.5× 188 2.8× 65 1.4× 44 1.8× 9 404
Xueyan Wang China 5 240 0.9× 48 0.2× 81 1.2× 94 2.0× 53 2.2× 7 391
Tanja Badovinac Črnjević Switzerland 9 238 0.9× 119 0.5× 50 0.8× 39 0.8× 106 4.4× 16 326
Reginald B. Ewesuedo United States 11 216 0.8× 81 0.4× 233 3.5× 139 3.0× 22 0.9× 29 450
T. Kouno Japan 7 215 0.8× 93 0.4× 68 1.0× 63 1.3× 33 1.4× 11 348
Christy Osgood United States 11 359 1.4× 129 0.6× 132 2.0× 59 1.3× 167 7.0× 19 541
M. Rowley United Kingdom 11 69 0.3× 51 0.2× 92 1.4× 24 0.5× 29 1.2× 17 301

Countries citing papers authored by Bei Wang

Since Specialization
Citations

This map shows the geographic impact of Bei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Wang more than expected).

Fields of papers citing papers by Bei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Wang. The network helps show where Bei Wang may publish in the future.

Co-authorship network of co-authors of Bei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Bei Wang. A scholar is included among the top collaborators of Bei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bei Wang. Bei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lai, Xiaoping, Tingting Li, Bailin Cong, et al.. (2025). Biodiversity and Conservation of Marine Mollusks in the Indo‐Pacific Convergence Zone. Ecology and Evolution. 15(11). e72364–e72364.
2.
Wang, Bei, Kaiyu Liu, Wenhao Huang, et al.. (2025). Spatial planning for dugong conservation: Assessing habitat suitability and conservation gaps in Indo-Pacific Convergence Zone. Marine Policy. 180. 106777–106777. 1 indexed citations
3.
Zhao, Linlin, Tingting Li, Bailin Cong, et al.. (2025). Marine Biodiversity Conservation Planning in the Indo-Pacific Convergence Zone Based on Ecological Spatial Analysis. Biology. 14(6). 700–700.
4.
Wynne, Chris, Bei Wang, Rong Deng, et al.. (2025). Pharmacokinetic bioequivalence of the fixed-dose combination of pertuzumab and trastuzumab administered subcutaneously using a handheld syringe or an on-body delivery system. Journal of Cancer Research and Clinical Oncology. 151(6). 188–188.
5.
Li, Chi‐Chung, Brendan C. Bender, Justin Wilkins, et al.. (2024). A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma. Clinical Pharmacology & Therapeutics. 117(2). 465–474. 3 indexed citations
6.
Li, Xiao-Bin, Lin Xu, Xiaohong Mu, et al.. (2024). A high-quality dataset featuring classified and annotated cervical spine X-ray atlas. Scientific Data. 11(1). 625–625. 4 indexed citations
7.
8.
Samineni, Divya, Leonid Gibiansky, Bei Wang, et al.. (2022). Pharmacokinetics and Exposure-Response Analysis of Venetoclax + Obinutuzumab in Chronic Lymphocytic Leukemia: Phase 1b Study and Phase 3 CLL14 Trial. Advances in Therapy. 39(8). 3635–3653. 7 indexed citations
9.
10.
11.
Luo, Yang, Wěi Li, Zefei Jiang, et al.. (2019). Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer. Anti-Cancer Drugs. 30(8). 866–872. 3 indexed citations
12.
Kirschbrown, Whitney P., Matts Kågedal, Bei Wang, et al.. (2019). Pharmacokinetic and exploratory exposure–response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study. Cancer Chemotherapy and Pharmacology. 83(6). 1147–1158. 9 indexed citations
13.
Kirschbrown, Whitney P., Bei Wang, Ihsan Nijem, et al.. (2019). Pharmacokinetic and exposure–response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer. Cancer Chemotherapy and Pharmacology. 84(3). 539–550. 9 indexed citations
14.
Kirschbrown, Whitney P., Chris Wynne, Matts Kågedal, et al.. (2018). Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study. The Journal of Clinical Pharmacology. 59(5). 702–716. 28 indexed citations
15.
Li, Chunze, Bei Wang, Russell Wada, et al.. (2017). Exposure–response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane. Cancer Chemotherapy and Pharmacology. 80(6). 1079–1090. 23 indexed citations
16.
Kågedal, Matts, Leonid Gibiansky, Jian Xu, et al.. (2017). Platform model describing pharmacokinetic properties of vc-MMAE antibody–drug conjugates. Journal of Pharmacokinetics and Pharmacodynamics. 44(6). 537–548. 9 indexed citations
17.
18.
Shen, Ben‐Quan, Daniela Bumbaca, Ola M. Saad, et al.. (2012). Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism. Current Drug Metabolism. 13(7). 901–910. 92 indexed citations
19.
20.
Wang, Bei, et al.. (2008). Automatic Sleep Stage Determination by Multi-Valued Decision Making Based on Conditional Probability with Optimal Parameters. SICE Journal of Control Measurement and System Integration. 1(6). 423–428.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia Basu Breakdown of academic impact, for papers by Anson K. Abraham Breakdown of academic impact, for papers by Mathilde Marchand Breakdown of academic impact, for papers by Stephen Eppler Breakdown of academic impact, for papers by Xueyan Wang Breakdown of academic impact, for papers by Tanja Badovinac Črnjević Breakdown of academic impact, for papers by Reginald B. Ewesuedo Breakdown of academic impact, for papers by T. Kouno Breakdown of academic impact, for papers by Christy Osgood Breakdown of academic impact, for papers by M. Rowley
Rankless by CCL
2026